Helicobacter Pylori Infection

There is a lack of adherence to current guidelines for the diagnosis, testing and treatment of Helicobacter pylori infection, suggesting the need for new and simpler treatments, according to a study published in GastroHep Advances.

In this video, C. Jonathan D. Foster, DO, FACOI, discussed a study on the use of vonoprazan-based regimens for the treatment of Helicobacter pylori infection presented at the ACG Annual Scientific Meeting.

C. Jonathan D. Foster, DO, FACOI, spoke with Healio about the utility of repeat Helicobacter pylori biopsies in patients with previously negative tests.

Healio Gastroenterology presents the following report on the top 10 peer-tested stories from the ACG Annual Scientific Meeting 2021.

This award goes to a gastroenterologist or hepatologist who consistently pushed the gastroenterology field forward through innovative treatments, practice management, patient care or research.

The AGA published the Clinical Practice Update expert review to provide guidance on the diagnosis and management of atrophic gastritis, in particular due to chronic Helicobacter pylori infection.

Macrolide and quinolone consumption positively correlated with Helicobacter pylori resistance in European countries, according to research published in Gut.

The American Gastroenterological Association published a new clinical practice update on the management of refractory Helicobacter pylori.

Researchers observed high helicobacter pylori infection seroprevalence among Hispanic/Latino individuals, which varied by nativity and background, according to study results.

In this podcast episode, we interview Barry Marshall, AC, FRACP, FRS, FAA, the legendary Nobel Laureate who discovered that peptic ulcer disease was caused by the bacteria Helicobacter pylori, not excess acid.